PAPER Wakasaya Y, Kawarabayashi T, Watanabe M, Yamamoto-Watanabe Y, Takamura A, Kurata T, Murakami T, Abe K, Yamada K, Wakabayashi K, Sasaki A, Westaway D, Hyslop PS, Matsubara E, Shoji M
SEARCH RESULTS
329930 RESULTS
PAPER Du YF, Yan P, Guo SG, Qu CQ
Effects of fibrillar Aβ(1-40) on the viability of primary cultures of cholinergic neurons and the expression of insulin signaling-related proteins.
Anat Rec (Hoboken). 2011 Feb;294(2):287-94. PubMed: 21235004PAPER Manthorpe J, Iliffe S
Viewpoint. Alzheimer's drugs debate.
Ment Health Today. 2010 Dec-2011 Jan;:31. PubMed: 21235054PAPER Trachtenberg AJ, Filippini N, Cheeseman J, Duff EP, Neville MJ, Ebmeier KP, Karpe F, Mackay CE
The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease.
Neurobiol Aging. 2012 Mar;33(3):618.e1-618.e13. PubMed: 21232817PAPER Vardy ER, Brown K, Stopford CL, Thompson JC, Richardson AM, Neary D, Kalsheker N, Morgan K, Mann DM, Snowden JS
Cognitive phenotypes in Alzheimer's disease and genetic variants in ACE and IDE.
Neurobiol Aging. 2011 Jan 11; PubMed: 21232820PAPER Mutlu NB, Değim Z, Yilmaz Ş, Eşsiz D, Nacar A
New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Drug Dev Ind Pharm. 2011 Jul;37(7):775-89. PubMed: 21231901PAPER Casarejos MJ, Solano RM, Gómez A, Perucho J, de Yébenes JG, Mena MA
The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells.
Neurochem Int. 2011 Mar;58(4):512-20. PubMed: 21232572PAPER Torralva T, Roca M, Gleichgerrcht E, Bonifacio A, Raimondi C, Manes F
Validation of the Spanish Version of the Addenbrooke's Cognitive Examination-Revised (ACE-R).
Neurologia. 2011 July - August;26(6):351-356. PubMed: 21232827PAPER Rostomian AH, Madison C, Rabinovici GD, Jagust WJ
Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.
J Nucl Med. 2011 Feb;52(2):173-9. PubMed: 21233181GFP (JL-8)
ANTIBODY monoclonal JL-8 manufacturer Cat# 632380, 20 µl<br />Cat# 632381, 200 µl<br />Reference: <br /><a href="/papers/retrieval-alzheimers-amyloid-precursor-protein-endosome-tgn-s655-phosphorylation-state" target="_new"&
Aβ, N-terminal (1E8)
ANTIBODY monoclonal 1E8 laboratory 1E8<br />(Paul Cutler,<br />SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex, UK<br />paper: <a href="http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T36-3
PAPER Zhang D, Guo Q, Bian C, Zhang J, Cai W, Su B
Expression of steroid receptor coactivator-1 was regulated by postnatal development but not ovariectomy in the hippocampus of rats.
Dev Neurosci. 2011;33(1):57-63. PubMed: 21228553PAPER Forni PE, Fornaro M, Guénette S, Wray S
A role for FE65 in controlling GnRH-1 neurogenesis.
J Neurosci. 2011 Jan 12;31(2):480-91. PubMed: 21228158PAPER Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, Kuo SW, Valori CF, Cox L, Sharrack B, Wharton SB, Ince PG, Shaw PJ, Azzouz M
Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis.
Brain. 2011 Feb;134(Pt 2):506-17. PubMed: 21228060PAPER Dowling P, Clynes M
Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers.
Proteomics. 2011 Feb;11(4):794-804. PubMed: 21229588Current Filters
No filters selected